We are live on
!
Find out more
CVSC
C.V. Starr & Co Portfolio holdings
AUM
$192M
1-Year Est. Return
35.69%
This Fund
S&P 500
This Quarter
Est. Return
-22.3%
1 Year Est. Return
+35.69%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$27.1M
AUM Growth
+$22.2M
(+450%)
Cap. Flow
+$27.6M
Cap. Flow
% of AUM
101.84%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Celularity
CELU
|
+$27.6M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 81.56% |
| 2 | Consumer Discretionary | 18.44% |
Similar funds
CA
AGA
VFA
KWM
SCGDR
KC
CCC
WIA
C.V. Starr & Co's Q4 2021 Portfolio in Review
As of Q4 2021, C.V. Starr & Co held 2 positions worth $27.1M, up 450% from $4.93M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
C.V. Starr & Co deployed $27.6M of net new capital in Q4 2021, opening 1 new position. Its largest new stake was Celularity: 432,035 shares worth $22.1M.
By sector, the portfolio is most concentrated in Healthcare at 82% of assets, followed by Consumer Discretionary.
- C.V. Starr & Co's largest Q4 2021 buy was Celularity: 432,035 shares worth $22.1M.
- C.V. Starr & Co's ten largest holdings make up 100% of its $27.1M portfolio in Q4 2021.
- C.V. Starr & Co opened 1 new position and closed 0 in Q4 2021.
- C.V. Starr & Co's portfolio value rose 450% quarter-over-quarter to $27.1M.
Based on C.V. Starr & Co's 13F filing for Q4 2021, filed 27 Jan 2022.